Lloyd Bod

435 total citations
10 papers, 247 citations indexed

About

Lloyd Bod is a scholar working on Immunology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Lloyd Bod has authored 10 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 4 papers in Molecular Biology and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Lloyd Bod's work include Immune Cell Function and Interaction (6 papers), Immune cells in cancer (4 papers) and T-cell and B-cell Immunology (4 papers). Lloyd Bod is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Immune cells in cancer (4 papers) and T-cell and B-cell Immunology (4 papers). Lloyd Bod collaborates with scholars based in France, Japan and Switzerland. Lloyd Bod's co-authors include Armelle Prévost‐Blondel, Renée Lengagne, Masashi Kato, Ludovic J. Wrobel, Frédérique‐Anne Le Gal, Laëtitia Douguet, Marie‐Françoise Avril, Valérie Molinier‐Frenkel, Flavia Castellano and Yolande Richard and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Cancer Cell.

In The Last Decade

Lloyd Bod

9 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lloyd Bod France	8	141	74	59	55	33	10	247
Laëtitia Douguet France	10	152 1.1×	96 1.3×	21 0.4×	95 1.7×	7 0.2×	13	304
Marisa K. Kilgour Canada	8	114 0.8×	118 1.6×	53 0.9×	63 1.1×	16 0.5×	9	268
Todd Triplett United States	10	123 0.9×	110 1.5×	10 0.2×	68 1.2×	9 0.3×	20	261
Silvia Martín Spain	4	68 0.5×	37 0.5×	9 0.2×	40 0.7×	27 0.8×	8	157
Chiara Bolognesi Italy	4	55 0.4×	58 0.8×	21 0.4×	92 1.7×	11 0.3×	18	320
April Bell United States	5	103 0.7×	60 0.8×	25 0.4×	70 1.3×	3 0.1×	10	236
Sara Lewis United States	7	34 0.2×	33 0.4×	11 0.2×	79 1.4×	61 1.8×	13	227
Lara Stepan United States	6	50 0.4×	167 2.3×	47 0.8×	95 1.7×	4 0.1×	7	318
Mingchao Wang China	6	24 0.2×	42 0.6×	45 0.8×	73 1.3×	33 1.0×	13	178

Countries citing papers authored by Lloyd Bod

Since Specialization

Citations

This map shows the geographic impact of Lloyd Bod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lloyd Bod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lloyd Bod more than expected).

Fields of papers citing papers by Lloyd Bod

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lloyd Bod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lloyd Bod. The network helps show where Lloyd Bod may publish in the future.

Co-authorship network of co-authors of Lloyd Bod

This figure shows the co-authorship network connecting the top 25 collaborators of Lloyd Bod. A scholar is included among the top collaborators of Lloyd Bod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lloyd Bod. Lloyd Bod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Bod, Lloyd. (2024). Finding the right friends: Stromal composition influences TLS formation in ovarian cancer. Cancer Cell. 42(11). 1811–1812. 4 indexed citations

Liu, Xin, Tatsuya Kobayashi, Pin‐Ji Lei, et al.. (2024). 1020 Inhibiting B-cell-mediated immunosuppression to enhance the efficacy of STING agonism in hepatocellular carcinoma. Regular and Young Investigator Award Abstracts. A1141–A1141.

Xiao, Sheng, Lloyd Bod, Nathalie Pochet, et al.. (2020). Checkpoint Receptor TIGIT Expressed on Tim-1+ B Cells Regulates Tissue Inflammation. Cell Reports. 32(2). 107892–107892. 46 indexed citations

Bod, Lloyd, Maryline Favier, Benoît Terris, et al.. (2018). Emerging Role of IL-4–Induced Gene 1 as a Prognostic Biomarker Affecting the Local T-Cell Response in Human Cutaneous Melanoma. Journal of Investigative Dermatology. 138(12). 2625–2634. 28 indexed citations

Douguet, Laëtitia, Lloyd Bod, Renée Lengagne, et al.. (2018). Inflammation drives nitric oxide synthase 2 expression by γδ T cells and affects the balance between melanoma and vitiligo associated melanoma. OncoImmunology. 7(9). e1484979–e1484979. 9 indexed citations

Bod, Lloyd, Renée Lengagne, Ludovic J. Wrobel, et al.. (2017). IL4-induced gene 1 promotes tumor growth by shaping the immune microenvironment in melanoma. OncoImmunology. 6(3). e1278331–e1278331. 28 indexed citations

Bod, Lloyd, Laëtitia Douguet, Cédric Auffray, et al.. (2017). IL-4–Induced Gene 1: A Negative Immune Checkpoint Controlling B Cell Differentiation and Activation. The Journal of Immunology. 200(3). 1027–1038. 30 indexed citations

Douguet, Laëtitia, Lloyd Bod, Renée Lengagne, et al.. (2016). Nitric oxide synthase 2 is involved in the pro-tumorigenic potential of γδ17 T cells in melanoma. OncoImmunology. 5(8). e1208878–e1208878. 26 indexed citations

Wrobel, Ludovic J., Lloyd Bod, Renée Lengagne, et al.. (2016). Propranolol induces a favourable shift of anti-tumor immunity in a murine spontaneous model of melanoma. Oncotarget. 7(47). 77825–77837. 65 indexed citations

10.

Douguet, Laëtitia, Julien Cherfils‐Vicini, Lloyd Bod, et al.. (2016). Nitric Oxide Synthase 2 Improves Proliferation and Glycolysis of Peripheral γδ T Cells. PLoS ONE. 11(11). e0165639–e0165639. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact